Back to Search
FADI SALLOUM, MD
MD
Internal Medicine Physician
NPI: 1205874831IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
4301065435(MI)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
OTHER
Class of 1993
Research & Publications (20)
A novel role of microRNA in late preconditioning: upregulation of endothelial nitric oxide synthase and heat shock protein 70.
PMID 19213952·Circ Res·2009
7-preclinical
cis-3, 4', 5-Trimethoxy-3'-aminostilbene disrupts tumor vascular perfusion without damaging normal organ perfusion.
PMID 18365199·Cancer Chemother Pharmacol·2009
7-preclinical
Anakinra in experimental acute myocardial infarction--does dosage or duration of treatment matter?
PMID 19005744·Cardiovasc Drugs Ther·2009
7-preclinical
Parecoxib inhibits apoptosis in acute myocardial infarction due to permanent coronary ligation but not due to ischemia-reperfusion.
PMID 19455055·J Cardiovasc Pharmacol·2009
4-observational
cGMP-hydrolytic activity and its inhibition by sildenafil in normal and failing human and mouse myocardium.
PMID 19546307·J Pharmacol Exp Ther·2009
7-preclinical
ERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice.
PMID 19286961·Am J Physiol Heart Circ Physiol·2009
7-preclinical
Sildenafil (Viagra) attenuates ischemic cardiomyopathy and improves left ventricular function in mice.
PMID 18223185·Am J Physiol Heart Circ Physiol·2008
7-preclinical
Right ventricular cardiomyocyte apoptosis in patients with acute myocardial infarction of the left ventricular wall.
PMID 18773983·Am J Cardiol·2008
8-other
Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction.
PMID 18474815·Circulation·2008
7-preclinical
Hypoxia inducible factor-1 upregulates adiponectin in diabetic mouse hearts and attenuates post-ischemic injury.
PMID 18287886·J Cardiovasc Pharmacol·2008
7-preclinical
Activation of hypoxia-inducible factor-1 via prolyl-4 hydoxylase-2 gene silencing attenuates acute inflammatory responses in postischemic myocardium.
PMID 17545479·Am J Physiol Heart Circ Physiol·2007
7-preclinical
Protective effects of parecoxib, a cyclo-oxygenase-2 inhibitor, in postinfarction remodeling in the rat.
PMID 18030068·J Cardiovasc Pharmacol·2007
7-preclinical
Adenosine A(1) receptor mediates delayed cardioprotective effect of sildenafil in mouse.
PMID 17920622·J Mol Cell Cardiol·2007
7-preclinical
Identification of protein disulfide isomerase as a cardiomyocyte survival factor in ischemic cardiomyopathy.
PMID 17825711·J Am Coll Cardiol·2007
7-preclinical
Improvement of cardiac function with parecoxib, a cyclo-oxygenase-2 inhibitor, in a rat model of ischemic heart failure.
PMID 17577107·J Cardiovasc Pharmacol·2007
7-preclinical
Sildenafil and vardenafil but not nitroglycerin limit myocardial infarction through opening of mitochondrial K(ATP) channels when administered at reperfusion following ischemia in rabbits.
PMID 17157308·J Mol Cell Cardiol·2007
4-observational
Rapamycin confers preconditioning-like protection against ischemia-reperfusion injury in isolated mouse heart and cardiomyocytes.
PMID 16769083·J Mol Cell Cardiol·2006
7-preclinical
Vardenafil: a novel type 5 phosphodiesterase inhibitor reduces myocardial infarct size following ischemia/reperfusion injury via opening of mitochondrial K(ATP) channels in rabbits.
PMID 16480739·J Mol Cell Cardiol·2006
7-preclinical
Hypoxia inducible factor-1 activation by prolyl 4-hydroxylase-2 gene silencing attenuates myocardial ischemia reperfusion injury.
PMID 16306444·Circ Res·2006
7-preclinical
Phosphodiesterase-5 inhibition with sildenafil attenuates cardiomyocyte apoptosis and left ventricular dysfunction in a chronic model of doxorubicin cardiotoxicity.
PMID 15811867·Circulation·2005
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 50 N PERRY ST
PONTIAC, MI 48342 - Phone
- (248) 338-5516
Quick Facts
- NPI
- 1205874831
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 33
- Publications
- 20
Are you this provider?
Claim Your Profile